RNA Binding Proteins: From Structure to Inhibitors

This inaugural conference will explore the latest developments in RNA-binding protein druggability. The program will explore the structural intricacies of RBPs, explaining how their conformations influence RNA interactions and function. The conference will also cover the latest advancements in inhibitor development for targeting these proteins, highlighting their potential as therapeutic agents in treating diseases, focusing on cancer pathologies.

Attendees will gain a comprehensive understanding of the molecular mechanisms underpinning RNA-protein interactions. They will also learn about the innovative strategies employed to modulate these pathways for therapeutic benefit, mainly in the cancer area.

Attendees will learn about:

· Novel therapies that target serious diseases like cancer.

· Integrative bioinformatics approaches.

· Advanced structural analysis techniques

· Collaborative research opportunities.

Program Topics

· Mechanisms of RNA-protein interactions

· Novel methods in RBP research

· RBP functions in cellular processes

· RBPs in development and disease

· Chemical modifications of RNA and the influence of epitranscriptome

· Structural biology of RNA-binding proteins

· Therapeutic targeting of RNA-protein interaction

· Focus on RNA therapeutics

Workshops

A Meet the Expert session will provide attendees with the opportunity to discuss their research and network with speakers and senior scientists. It will focus on bottlenecks in scientific project development and challenges regarding journal selection and publication.

A Career Development Workshop for early-career researchers will be held in a roundtable format with a focus on transitions from PhD to post-doc and from post-doc to PI.